MILWAUKEE, June 18, 2020 /PRNewswire/ — Mpirik, an A.I. healthcare technology company that develops automated patient screening models for cardiovascular disease to drive actionable knowledge, quality and research, has named Paul Mirabella and Hooman C. Hakami to its Board of Directors. Mr. Mirabella has more than 40 years of experience in the healthcare industry most notably as […]
Financial
CryoLife Announces Offering of Convertible Senior Notes Due 2025
ATLANTA, June 18, 2020 /PRNewswire/ — CryoLife, Inc. (NYSE: CRY) (“CryoLife” or “the Company”), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it intends to offer, subject to market conditions and other factors, $100,000,000 aggregate principal amount of convertible senior notes due 2025 (the “Notes”) in a private placement to qualified […]
BioCardia Announces Pricing of $10 Million Public Offering
SAN CARLOS, Calif., June 17, 2020 (GLOBE NEWSWIRE) — BioCardia®, Inc. NasdaqCM: BCDA (the “Company”), a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today announced the pricing of its public offering of 4,762,000 shares of common stock at a price to the public of $2.10 per share. BioCardia […]
Amarin Announces Patent Litigation Settlement Agreement with Apotex Inc.
DUBLIN, Ireland and BRIDGEWATER, N.J., June 16, 2020 (GLOBE NEWSWIRE) — Amarin Corporation plc (NASDAQ:AMRN) announced today a settlement agreement with Apotex Inc. (Apotex) that resolves patent litigation that would have resulted from the previously disclosed abbreviated new drug application (ANDA) filed by Apotex with U.S. Food and Drug Administration […]
Shockwave Announces Proposed Public Offering of Common Stock
SANTA CLARA, Calif., June 16, 2020 (GLOBE NEWSWIRE) — Shockwave Medical, Inc. (“Shockwave”) (Nasdaq: SWAV) today announced it has commenced an underwritten public offering of 1,700,000 shares of its common stock. All of the shares of common stock are being offered by Shockwave. In addition, Shockwave intends to grant the […]
Keystone Heart, A Venus Medtech Company, Acquires 510 Kardiac Devices, Inc.
TAMPA, Fla., June 16, 2020 /PRNewswire/ — Keystone Heart, LTD., a medical device innovator driven to redefine the standard of structural heart care, today announced it has acquired 510 Kardiac Devices, Inc., a privately-held medical device company and makers of the Lim Transseptal System. The Lim Transseptal System was designed to meet the demands […]
Proximo Medical and Coala Life Partner for Commercialization in Select U.S. Markets
CASTLE PINES, Colo., June 16, 2020 /PRNewswire/ — Today Proximo Medical, LLC, a business acceleration solution that addresses medical device commercialization challenges among startup and established medical device technologies looking to expand adoption in the U.S., announced a partnership with Coala Life, a leading Swedish-headquartered digital health company, in select U.S. markets. The COALA® Heart Monitor provides […]
Abiomed Appoints New Chief Medical Officer Charles Simonton, M.D.
DANVERS, Mass.–(BUSINESS WIRE)–Abiomed (Nasdaq: ABMD), maker of the Impella heart pump, announced today it has appointed Charles (Chuck) Simonton, M.D., as vice president and chief medical officer. Dr. Simonton is renowned for his leadership in product development and large-scale clinical trials. He was most recently at Abbott Vascular where he served as chief medical officer […]
Puzzle Medical Devices Inc. announces the closing of a first financing round; provides update on its minimally invasive transcatheter heart pump
MONTREAL, June 15, 2020 /PRNewswire/ – Puzzle Medical Devices Inc., (www.puzzlemed.com) announces the closure of its first convertible debenture financing round led by Canadian entrepreneur Pascal Labrecque. Other participants include a United States venture capital firm, entrepreneurs and interventional cardiologists practicing in Canada, the United States and Europe. This investment follows the successful completion of Puzzle Medical’s first preclinical studies […]
Endonovo Therapeutics Announces First Quarter Fiscal 2020 Financial Results
Los Angeles, CA, June 15, 2020 (GLOBE NEWSWIRE) — Endonovo Therapeutics, Inc. (OTCQB: ENDV) (“Endonovo” or the “Company”), today announces financial and operating results for the first quarter ended March 31, 2020. Company improved financial and operating results are reflected in every major financial category, as compared to first quarter […]



